A recent Phase III trial has kicked off to evaluate the performance of a promising new antibiotic called Compound X in the management of common bladder issues. The trial is being conducted at various hospitals across the world and will enroll thousands of participants with varying types of UTIs. Clinical Trialists are optimistic that Compound X rev